Genetic basis of gall stone disease


  • Potential conflict of interest: Nothing to report.

To the Editor:

The recently published article by von Kampen et al.[1] dissecting the pathobiology of cholesterol gall stone disease (GSD) using sophisticated genetic approaches appears to be indeed interesting in the postgenomic era. Linkage and association studies have identified the cholesterol transporter ABCG5/G8 as a genetic determinant of gallstone formation, or LITH gene, in humans.[2]

The research group reports two disease-associated variants, ABCG5-R50C and ABCG8-D19H, in pooled clinical samples (cases and controls) in human populations, including specimens from India. The study's overall quality could have been enhanced with more meaningful interpretation of the data if the authors had maintained homogeneity in case and control numbers. Stratified/subgroup analysis in females and males recruited in the study would further aid in understanding the gender-specific genetic background of cholelithiasis and gall stone formation. Further, I wish to comment that SNP T400K in the ABCG8 gene has also been investigated in GSD pathophysiology in an Indian population3; this particular genetic variant could have been included for genetic mapping in clinical samples drawn from Germany, Chile, Denmark, India, and China for a better understanding of the precise mechanism(s) of hypercholesterolemia and gallstone risk in disease-susceptible human populations. Moreover, family/twin studies and animal model studies using inbred strains of mice provide evidence that GSD is, in part, genetically determined.[4]

Therefore, a more comprehensive, well-designed global collaborative study approach is needed to fully understand the genetic basis of GSD in diverse ethnic groups and accordingly identify rational drug targets for early prevention of GSD.

  • Saumya Pandey, M.Sc., Ph.D.

  • University of Texas Medical Branch, Galveston, TX